Holen Sie sich die Stockscreener-App
8.69
3.58%
0.30
Handel nachbörslich:
8.65
-0.04
-0.46%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Discipline and Rules-Based Execution in NVAX Response - Stock Traders Daily
Novavax Inc stock (US6707721049): Is its vaccine pipeline strong enough to unlock new upside? - AD HOC NEWS
SHAH CAPITAL MANAGEMENT Increases Stake in Novavax Inc - GuruFocus
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax Inc stock (US6707721049): Is its vaccine pivot strong enough to unlock new upside? - AD HOC NEWS
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance UK
Synlogic and Novavax Face Off in Financial Analysis - National Today
Novavax, Inc. Revenue Breakdown – BSESOF:NVV1 - TradingView — Track All Markets
Why Novavax (NVAX) Is Up 5.5% After Activist Pressure Meets New R&D Leadership And What's Next - Yahoo Finance
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Is Novavax (NVAX) Being Pulled Between R&D Ambitions and Activist Demands for Discipline? - simplywall.st
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Novavax (NVAX): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
US CDC delays publishing report showing COVID vaccine benefits, WaPo reports - Reuters
B. Riley Raises Price Target on Novavax to $18 from $16, Keeps Buy Rating - marketscreener.com
Novavax (NVAX) Receives a Sell from Bank of America Securities - The Globe and Mail
Shah Capital Pushes for Changes at Novavax (NVAX) - GuruFocus
Why is NVAX stock surging today? - MSN
Shah Capital Blasts Novavax Strategy In New Letter To Board - Citeline News & Insights
Shah Capital's Plan to Vote Against Novavax Board Nominees | PharmExec - Pharmaceutical Executive
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees - Pharmaceutical Executive
Investor calls for Novavax to slash costs, cut board as vaccine sales disappoint - The Business Journals
Shah Capital intends to vote against Novavax's board nominees, executive compensation - Reuters
Activist investor revives campaign to overhaul Novavax board - BioPharma Dive
Novavax Faces Shareholder Revolt As Shah Capital Criticizes StrategyNovavax (NASDAQ:NVAX) - Benzinga
3 Reasons NVAX is Risky and 1 Stock to Buy Instead - Yahoo Finance
Novavax rises as Shah Capital calls for changes (NVAX:NASDAQ) - Seeking Alpha
Assessing Novavax (NVAX) Valuation After Renewed Focus On Covid And Malaria Vaccine Deals - Yahoo Finance
Novavax stock surges as activist pushes for board changes By Investing.com - Investing.com Canada
Why Is NVAX Stock Surging Today? - Stocktwits
Shah Capital (NVAX) discloses 9.11% Novavax stake and plans votes against board - Stock Titan
NVAX Technical Analysis | Trend, Signals & Chart Patterns | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Is Novavax (NVAX) A Potential Opportunity After Recent Share Price Weakness - Yahoo Finance
Novavax Soars After Covid Vaccine Secures Full FDA Approval - MSN
Traders Buy Large Volume of Call Options on Novavax (NASDAQ:NVAX) - MarketBeat
Levels Update: Is Novavax Inc benefiting from interest rate changes2026 Sector Moves & Weekly Setup with ROI Potential - baoquankhu1.vn
Novavax, Inc. (NVAX) stock price, news, quote and history - Yahoo Finance UK
Behavioral Patterns of NVAX and Institutional Flows - Stock Traders Daily
Novavax Inc stock: Biotech innovator or fading COVID play? - AD HOC NEWS
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know - Yahoo Finance
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Novavax (NASDAQ:NVAX) Shares Down 5.4%Should You Sell? - MarketBeat
Novavax (NVAX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Investors heavily search Novavax, Inc. (NVAX): Here is what you need to know - MSN
Novavax Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Novavax Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Novavax (XTER:NVV1) PB Ratio : (As of Mar. 31, 2026) - GuruFocus
New Novavax R&D Leader Raises Questions On Valuation Gap And Outlook - Yahoo Finance
Shah Capital Management Purchases 2,747,000 Shares of Novavax, Inc. $NVAX - MarketBeat
Novavax names Robert Walker as R&D head By Investing.com - Investing.com South Africa
Novavax Stock Crosses 200-Day Moving Average - nationaltoday.com
Novavax (NASDAQ:NVAX) Stock Price Passes Above 200 Day Moving AverageHere's Why - MarketBeat
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Novavax names new R&D chief as previous leader departs after less than two years - The Business Journals
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):